159 related articles for article (PubMed ID: 12814865)
1. N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study.
Nudmamud S; Reynolds LM; Reynolds GP
Biol Psychiatry; 2003 Jun; 53(12):1138-41. PubMed ID: 12814865
[TBL] [Abstract][Full Text] [Related]
2. Choline Compounds of the Frontal Lobe and Temporal Glutamatergic System in Bipolar and Schizophrenia Proton Magnetic Resonance Spectroscopy Study.
Galińska-Skok B; Małus A; Konarzewska B; Rogowska-Zach A; Milewski R; Tarasów E; Szulc A; Waszkiewicz N
Dis Markers; 2018; 2018():3654894. PubMed ID: 30595760
[TBL] [Abstract][Full Text] [Related]
3. Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorder.
Reynolds LM; Reynolds GP
J Psychiatr Res; 2011 Jan; 45(1):54-9. PubMed ID: 20684832
[TBL] [Abstract][Full Text] [Related]
4. Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain.
Reynolds LM; Cochran SM; Morris BJ; Pratt JA; Reynolds GP
Schizophr Res; 2005 Mar; 73(2-3):147-52. PubMed ID: 15653257
[TBL] [Abstract][Full Text] [Related]
5. Investigation of Heschl's gyrus and planum temporale in patients with schizophrenia and bipolar disorder: a proton magnetic resonance spectroscopy study.
Atagün MI; Şıkoğlu EM; Can SS; Karakaş-Uğurlu G; Ulusoy-Kaymak S; Çayköylü A; Algın O; Phillips ML; Moore CM; Öngür D
Schizophr Res; 2015 Feb; 161(2-3):202-9. PubMed ID: 25480359
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders.
Cecil KM; DelBello MP; Sellars MC; Strakowski SM
J Child Adolesc Psychopharmacol; 2003; 13(4):545-55. PubMed ID: 14977467
[TBL] [Abstract][Full Text] [Related]
7. Reduced N-acetylaspartate in the temporal cortex of rats reared in isolation.
Harte MK; Powell SB; Reynolds LM; Swerdlow NR; Geyer MA; Reynolds GP
Biol Psychiatry; 2004 Aug; 56(4):296-9. PubMed ID: 15312819
[TBL] [Abstract][Full Text] [Related]
8. Proton magnetic resonance spectroscopy (H-MRS) studies of schizophrenia.
Rowland L; Bustillo JR; Lauriello J
Semin Clin Neuropsychiatry; 2001 Apr; 6(2):121-30. PubMed ID: 11296312
[TBL] [Abstract][Full Text] [Related]
9. MR spectroscopic evaluation of N-acetylaspartate's T2 relaxation time and concentration corroborates white matter abnormalities in schizophrenia.
Tunc-Skarka N; Weber-Fahr W; Hoerst M; Meyer-Lindenberg A; Zink M; Ende G
Neuroimage; 2009 Nov; 48(3):525-31. PubMed ID: 19573608
[TBL] [Abstract][Full Text] [Related]
10. T2 relaxation time abnormalities in bipolar disorder and schizophrenia.
Ongür D; Prescot AP; Jensen JE; Rouse ED; Cohen BM; Renshaw PF; Olson DP
Magn Reson Med; 2010 Jan; 63(1):1-8. PubMed ID: 19918902
[TBL] [Abstract][Full Text] [Related]
11. Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect.
Heimberg C; Komoroski RA; Lawson WB; Cardwell D; Karson CN
Psychiatry Res; 1998 Aug; 83(2):105-15. PubMed ID: 9818736
[TBL] [Abstract][Full Text] [Related]
12. Decreased N-acetylaspartate in children with familial bipolar disorder.
Chang K; Adleman N; Dienes K; Barnea-Goraly N; Reiss A; Ketter T
Biol Psychiatry; 2003 Jun; 53(11):1059-65. PubMed ID: 12788251
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid composition of the postmortem prefrontal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder.
Hamazaki K; Maekawa M; Toyota T; Dean B; Hamazaki T; Yoshikawa T
Psychiatry Res; 2015 Jun; 227(2-3):353-9. PubMed ID: 25858798
[TBL] [Abstract][Full Text] [Related]
14. What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update.
Abbott C; Bustillo J
Curr Opin Psychiatry; 2006 Mar; 19(2):135-9. PubMed ID: 16612192
[TBL] [Abstract][Full Text] [Related]
15. N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia.
Jessen F; Fingerhut N; Sprinkart AM; Kühn KU; Petrovsky N; Maier W; Schild HH; Block W; Wagner M; Träber F
Schizophr Bull; 2013 Jan; 39(1):197-205. PubMed ID: 21914645
[TBL] [Abstract][Full Text] [Related]
16. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium.
Johnston-Wilson NL; Sims CD; Hofmann JP; Anderson L; Shore AD; Torrey EF; Yolken RH
Mol Psychiatry; 2000 Mar; 5(2):142-9. PubMed ID: 10822341
[TBL] [Abstract][Full Text] [Related]
17. Neurochemical alterations in anterior cingulate cortex in bipolar disorder: a proton magnetic resonance spectroscopy study (1H-MRS).
Galińska-Skok B; Konarzewska B; Kubas B; Tarasów E; Szulc A
Psychiatr Pol; 2016; 50(4):839-848. PubMed ID: 27847932
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopic imaging of gray and white matter in bipolar-I and schizophrenia.
Bustillo JR; Jones T; Qualls C; Chavez L; Lin D; Lenroot RK; Gasparovic C
J Affect Disord; 2019 Mar; 246():745-753. PubMed ID: 30623820
[TBL] [Abstract][Full Text] [Related]
19. Decreased left frontal lobe N-acetylaspartate in schizophrenia.
Deicken RF; Zhou L; Corwin F; Vinogradov S; Weiner MW
Am J Psychiatry; 1997 May; 154(5):688-90. PubMed ID: 9137129
[TBL] [Abstract][Full Text] [Related]
20. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder.
Deicken RF; Pegues MP; Anzalone S; Feiwell R; Soher B
Am J Psychiatry; 2003 May; 160(5):873-82. PubMed ID: 12727690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
